Kunming Longjin Pharmaceutical Co., Ltd. (002750.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap876.92M
Enterprise Value618.13M
P/E Ratio-5.9
PEG Ratio-0.11
Price/Sales Ratio3.55
Price/Book Ratio0.5
Enterprise/Revenue-0.34
Enterprise/EBITDA0.79

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.62
Operating Margin-0.66
AD

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.08

Income Statement

Revenue66.48M
Revenue/Share0.17
Gross Profit27.06M
EBITDA-28.61M
Net Income-41.44M
Diluted EPS-0.1

Balance Sheet

Total Cash270.29M
Total Cash/Share0.74
Total Debt1.81M
Total Debt/Equity0.01
Current Ratio6.95
Book Value Per Share1.23

Price History

52-Week Change-72.56
52-Week High3.12
52-Week Low0.56
Moving Average 50 Days0.98
Moving Average 200 Days1.71

Statistics

Average Volume6.62M
Shares Outstanding400.5M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor2:1
Last Split DateMay 18, 2016
AD